Anixa Biosciences (ANIX) Share-based Compensation (2010 - 2026)
Anixa Biosciences' Share-based Compensation came in at $637,000 for fiscal Q3 2026 (quarter ended Jul 31, 2026), down 23.2% from $829,000 a year earlier.
Powered by 
Analysis
Anixa Biosciences (ANIX) Share-based Compensation (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Jul 31, 2026, Anixa Biosciences reported Share-based Compensation of $3.29 million, down 13.5% year-over-year; for FY2025 (ended Oct 31, 2025), it came in at $3.68 million, down 16.7% from FY2024.
- Share-based Compensation carries a five-year compound annual growth rate of -1.3% (FY2020 to FY2025).
- Going back by fiscal year, Share-based Compensation was $4.42 million in FY2024 (unchanged), $4.42 million in FY2023 (-26.3%), $6 million in FY2022 (-20.0%) and $7.5 million in FY2021 (+91.3%).
- The fiscal Q3 2026 figure represents the lowest quarterly Share-based Compensation since fiscal Q2 2018.
- The fastest year-over-year change in Share-based Compensation over five years came in fiscal Q4 2021 (growth of 197.8%), and the weakest in fiscal Q4 2022 (a decline of 60.3%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 170.20 Mn |
| 10 | Anixa Biosciences | 101.33 Mn | 100.06 Mn | - | 637,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 637,000.00 |
| Oct 31, 2025 | 859,000.00 |
| Jul 31, 2025 | 829,000.00 |
| Apr 30, 2025 | 962,000.00 |
| Jan 31, 2025 | 1.03 Mn |
| Oct 31, 2024 | 980,000.00 |
| Jul 31, 2024 | 1.09 Mn |
| Apr 30, 2024 | 1.24 Mn |
| Jan 31, 2024 | 1.11 Mn |
| Oct 31, 2023 | 1.16 Mn |
| Jul 31, 2023 | 1.15 Mn |
| Apr 30, 2023 | 1.16 Mn |
| Jan 31, 2023 | 957,000.00 |
| Oct 31, 2022 | 1.07 Mn |
| Jul 31, 2022 | 1.33 Mn |
| Apr 30, 2022 | 1.46 Mn |
| Jan 31, 2022 | 2.14 Mn |
| Oct 31, 2021 | 2.70 Mn |
| Jul 31, 2021 | 3.05 Mn |
| Apr 30, 2021 | 881,000.00 |
API Access
Anixa Biosciences Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=ANIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "ANIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=ANIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();